
-
2015
Company Description
TNK Therapeutics develops chimeric antigen receptor immunotherapy programs.
TNK Therapeutics develops chimeric antigen receptor immunotherapy programs.
-
Manufacturer:
Science and Engineering -
Formed:
2015 -
Company Website:
-
Company E-mail:
-
Company Address:
6042 Cornerstone Court West Suite BSan Diego, CAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits